Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Finopotamus logo — Fintech News for Hungry CUs

Finopotamus

Fintech News for Hungry CUs

Founded 2020 United States San Diego, United States 4 employees Venture round Total: $6.35M Biotechnology, Health Care +1

General Information

Company Name Finopotamus
Founded Year 2020
Location United States San Diego, United States
Founders / Decision Makers
Team member
Employees 4
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Finopotamus. To contact Finopotamus, visit finopotamus.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Finopotamus compare?

A PDF of Finopotamus and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Finopotamus soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Finopotamus

KelSie Biotech is a biotechnology startup headquartered in the United States, founded in 2017. Their recent Venture Round investment, with a value of $1.35M, took place on 02 April 2021. The company's focus lies in providing Fintech News for Hungry CUs, which was developed by renowned journalists in the credit union technology space. Their platform, Finopotamus, offers a space for individuals to submit press releases or pitches for consideration, indicating an openness to collaboration and engagement with potential stakeholders. With its emphasis on biotechnology, health care, and pharmaceuticals, KelSie Biotech is positioned within rapidly growing and essential sectors, thus warranting attention from venture capitalists looking to invest in impactful and innovative startups.

Business keywords: biotech, pharmaceuticals, drug delivery, bioavailability, APIs, technology, innovation, drug formulation, inhalable products, sublingual wafer, innovative drug delivery, patented technology

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $1.35M -
02 Apr 2021
Series A $5.00M 2
Salveo Capital Arcadian Capital
Salveo Capital, Arcadian Capital
31 May 2019

Finopotamus Alternatives & Competitors

View All Alternatives
Finopotamus vs
Pure Green Pharmaceuticals
Pure Green Pharmaceuticals

Crafting advanced cannabinoid treatments for rapid relief and enhanced bioavailability through innov...

Venture round
Health Care, Pharmaceutical
Finopotamus vs
Psycheceutical
Psycheceutical United States

Groundbreaking biotech solutions for safer, more effective psychedelic therapeutics.

Post-IPO Equity
4 employees
Biotechnology, Life Sciences
Finopotamus vs
Nanoform
Nanoform Finland

Nanoform uses platform technologies to develop innovative nanoparticle medicines, reducing clinical...

Grant
Biotechnology, Pharmaceutical
View all alternatives

FAQ About Finopotamus

Fintech News for Hungry CUs
Finopotamus was founded in 2020.
Finopotamus is headquartered in San Diego, United States.
Finopotamus operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on biotech, pharmaceuticals, drug delivery and bioavailability.
Finopotamus has approximately 4 employees.
Finopotamus has completed 2 funding rounds, raising a total of $6.35M. The latest funding stage is Venture round.
Top alternatives and competitors to Finopotamus include Pure Green Pharmaceuticals, Psycheceutical, Nanoform, Rani Therapeutics, AbTis | 앱티스. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Finopotamus and Pure Green Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Finopotamus, https://bouncewatch.com/company/kelsie-biotech, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout